Abstract
OBJECTIVE: Success of longitudinal studies depends on retention of participants. We examined characteristics as predictors of retention among participants with prediabetes and type 2 diabetes (T2D) in the Diabetes Prevention Program (DPP) and the follow-up DPP Outcomes Study. RESEARCH DESIGN AND METHODS: A total of 3,234 adults at high risk of T2D joined the DPP (1996–1999, mean age 51 ± 10 years). They were randomized to lifestyle, metformin, or placebo intervention, and then followed through 2020. Logistic regression models estimated the association between baseline sociodemographic, clinical and psychosocial characteristics (life events, family functioning, social support), and short-term retention (∼3 years). Cox proportional hazards models, censoring at death, estimated the association between baseline and time-varying characteristics and time to dropout over the entire 20 years of follow-up. RESULTS: Among surviving participants (n = 3,218), 93% were retained after 3 years, and 75% of those surviving remained engaged over 20 years. Younger age was associated with dropout during DPP and over 20 years of follow-up. Female sex, non-White race and ethnicity, employment, and lack of baseline depressive symptoms were associated with better long-term retention. Over time, better health state (SF-36) (hazard ratio [HR]: 0.89 per 0.1 point; 95% CI: 0.83–0.95) was associated with retention. Greater BMI (HR: 1.06 per 5 kg/m2; 95% CI: 1.00–1.12), more recent life events (HR: 1.08; 95% CI: 1.02–1.14), and depressive symptoms (HR: 1.11 per 5 points; 95% CI: 1.05–1.18) were associated with reduced retention. Among adults 45–59 years of age at baseline, development of T2D was associated with better retention (HR: 0.75; 95% CI: 0.58–0.97). CONCLUSIONS: Twenty-year retention of a racially and geographically diverse cohort with prediabetes is possible. Retention was associated with age, psychosocial factors, T2D development, and BMI.
Funding Information
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK048349, U01 DK048381, U01 DK048468)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK048387, U01 DK048407, U01 DK048443)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK048397, U01 DK048412, U01 DK048404)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK048400)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK048411, U01 DK048406, U01 DK048380)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK048434, U01 DK048485, U01 DK048375)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK048489, U01 DK048339, U01 DK048377,)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK048514, U01 DK048437, U01 DK048413)

This publication has 35 references indexed in Scilit: